Genetic research in coronary heart disease.
Coronary heart disease research along genetic lines is difficult. Studies in molecular genetics of apolipoprotein and receptor variability appear most promising in the near future. However, unexpected discoveries and methodology may turn up that may completely change the field. Exclusive concentration on lipid research therefore should be avoided. It is likely that most advances will come from carefully designed studies that ask specific questions. Such research design is appropriate not only for laboratory studies but also for clinical and epidemiological investigations. The collaboration of clinicians, biochemists, geneticists, epidemiologists, and statisticians is likely to lead to better understanding of coronary heart disease.
D000483:Alleles; D001053:Apolipoproteins / Q000235:genetics; D001161:Arteriosclerosis / Q000235:genetics; D002784:Cholesterol / Q000235:genetics; D008078:Cholesterol, LDL; D003327:Coronary Disease / Q000235:genetics*; D005260:Female; D005820:Genetic Testing; D006801:Humans; D006949:Hyperlipidemias / Q000235:genetics; D006938:Hyperlipoproteinemia Type II / Q000235:genetics; D006973:Hypertension / Q000235:genetics; D008077:Lipoproteins, LDL / Q000235:genetics; D008297:Male; D008957:Models, Genetic; D011110:Polymorphism, Genetic; D011956:Receptors, Cell Surface / Q000235:genetics; D011973:Receptors, LDL; D012306:Risk
D001053:Apolipoproteins; D008078:Cholesterol, LDL; D008077:Lipoproteins, LDL; D011956:Receptors, Cell Surface; D011973:Receptors, LDL; D002784:Cholesterol